Stage FocusSeed, Series A, Series B+
GeographyRest of World, Europe, US
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedTech
Technical BenchStrong
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio
Brandon Capital was founded in 2007 and has grown into Australia's largest life sciences venture capital firm, surpassing $1B in total AUM. Fund VI closed at AU$439M (US$288M) in 2024, the largest to date. The firm is the licensed manager for the Australian Government's $500M Biomedical Translation Fund, which provides dollar-for-dollar matching, and the National Reconstruction Fund committed an a...
Notable Investments
V
VaxxasA
AdvanCellM
Myricx BioO
OncoRes MedicalP
PolyActivaSimilar Funds
Abingworth
London, United Kingdom
DeepTech NativeBiotechMedTechSeedSeries A
Leaps by Bayer
Leverkusen, Germany
DeepTech NativeBiotechAgriTechMedTechSeedSeries A
M Ventures (Merck)
Amsterdam, Netherlands
DeepTech NativeBiotechSemiconductorsAdvanced MaterialsSeedSeries A
MPM Capital
Boston, United States
DeepTech NativeBiotechMedTechSeedSeries A
Pontifax
Herzliya, Israel
DeepTech NativeBiotechMedTechSeedSeries A
Sofinnova Partners
Paris, France
DeepTech NativeBiotechMedTechClimate TechSeedSeries A